These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15361404)

  • 1. Use of minocycline in rheumatoid arthritis: a district general hospital experience.
    Suresh E; Morris IM; Mattingly PC
    Ann Rheum Dis; 2004 Oct; 63(10):1354-5. PubMed ID: 15361404
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
    Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
    Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline-induced hyperpigmentation in rheumatoid arthritis.
    Fay BT; Whiddon AP; Puumala S; Black NA; O'Dell JR; Mikuls TR
    J Clin Rheumatol; 2008 Feb; 14(1):17-20. PubMed ID: 18431092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis.
    Emery P; Suarez-Almazor M
    Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiologic-clinical study of rheumatoid polyarthritis in Tunisia].
    Elloumi M; Cheour E; Bouagina E; Sahli H; Elleuch M; Meddeb N; Sellami S
    Tunis Med; 1998 Nov; 76(11):397-400. PubMed ID: 9881049
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic therapy for rheumatoid arthritis. Scientific and anecdotal appraisals.
    Trentham DE; Dynesius-Trentham RA
    Rheum Dis Clin North Am; 1995 Aug; 21(3):817-34. PubMed ID: 8619101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of DMARDs-resistant rheumatoid arthritis with minocycline: a local experience among the Chinese.
    Lai NS; Lan JL
    Rheumatol Int; 1998; 17(6):245-7. PubMed ID: 9592865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?
    O'Dell JR
    Drugs; 1999 Mar; 57(3):279-82. PubMed ID: 10193682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
    Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
    [No Abstract]   [Full Text] [Related]  

  • 10. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 11. [Minocycline in the treatment of rheumatoid arthritis].
    Alusík S
    Vnitr Lek; 1998 Aug; 44(8):502-4. PubMed ID: 10358459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
    van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
    Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study.
    Ogrendik M; Hakguder A; Keser N
    Rheumatology (Oxford); 2006 May; 45(5):636-7. PubMed ID: 16436488
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
    Nagashima T; Okubo-Fornbacher H; Aoki Y; Kamata Y; Kimura H; Kamimura T; Nara H; Iwamoto M; Yoshio T; Okazaki H; Minota S
    J Rheumatol; 2008 May; 35(5):936-8. PubMed ID: 18464318
    [No Abstract]   [Full Text] [Related]  

  • 15. Tight control in rheumatoid arthritis improves outcomes.
    Ostör AJ; Conaghan PG
    Practitioner; 2009 Mar; 253(1716):29-32. PubMed ID: 19418700
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
    Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J
    Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFalpha inhibitors.
    Davas EM; Alexiou I; Boulbou M; Koutroumpas A; Makaritsis K; Stathakis N; Sakkas LI
    J Infect; 2008 Nov; 57(5):418-20. PubMed ID: 18760485
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Bharadwaj A; Agrawal S; Batley M; Hammond A
    Rheumatology (Oxford); 2008 Feb; 47(2):222. PubMed ID: 18056146
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N; Max R; Schiller M; Briem S; Lorenz HM
    Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
    [No Abstract]   [Full Text] [Related]  

  • 20. Should minocycline be used to treat rheumatoid arthritis?
    Panush RS; Thoburn R
    Bull Rheum Dis; 1996 Apr; 45(2):2-5. PubMed ID: 8901389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.